NCT00298714View on ClinicalTrials.gov

Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C

PHASE4CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

January 31, 2006

Conditions

Chronic Hepatitis CLiver Fibrosis

Interventions

DRUG

Losartan

All Listed Sponsors

lead

Hospital Clinic of Barcelona

OTHER

NCT00298714 - Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C | Biotech Hunter | Biotech Hunter